Biologicals

Technical Report Series: biological products: general recommendations

Guidelines on evaluation of similar Biotherapeutic Products (SBPs), ECBS, 19-23 October 2009

Biological products, use of animal cells as in vitro substrates

Title 1: Requirements for the use of animal cells as in vitro substrates for the production of biologicals; Revised 1996, TRS No 878, Annex 1
Title 2: Requirements for the use of animal cells as in vitro substrates for the production of biologicals; Addendum 2003

Biological products, regulation and licensing

Title 1: Regulation and licensing of biological products in countries with newly developing Regulatory Authorities; Adopted at ECBS 1994; Reference: TRS No 858, Annex 1
Title 2: Guidelines for national authorities on quality assurance for biological products; Adopted at ECBS 1991; Reference: TRS No 822, Annex 2

Biological products, GMP

Title 1: Good Manufacturing Practices for biological products; Adopted 1991, TRS no 822, Annex 1

Biological products, rDNA

Title: Biological Products prepared by recombinant DNA technology; Adopted 1990, TRS No 814, Annex 3

Biological products, sterility

Title: General requirements for the sterility of biological substances Revised 1973, TRS No 530, Annex 4
Amendment 1995, TRS No 872, Annex 3

Technical Report Series No. 822, 1992 Annex 3

Guidelines for assurîng the quality of monoclonal antibodies for use in humans

New Publications

Upcoming events

WHO Informal consultation on Recommendations to assure the quality, safety and efficacy of recombinant human papillomavirus virus-like particle (HPV-VLP) vaccines

11-12 November 2014, Geneva, Switzerland

Contacts

Quality, Safety and Standards (QSS)
Immunization, Vaccines and Biologicals (IVB)
World Health Organization (WHO)
Avenue Appia 20
1211 Geneva 27, Switzerland
Fax No. +41 22 7914971